The specialized lining of the urinary tract, the urothelium, which extends from the renal pelvis
to the urethra, is a source of the 5th most common cancer, responsible for approximately 3…

BACKGROUND Micropapillary bladder carcinoma is a rare variant of urothelial carcinoma.
To improve understanding of this disease, the authors performed a retrospective review of …

Patient risk stratification is essential for optimal management of patients with bladder cancer.
Risk status determines the application and timing of therapeutic interventions such as …

… Colin PN Dinney Colin PN Dinney … Pettaway, Colin PN Dinney; Interleukin 8 Expression
Regulates Tumorigenicity and Metastases in Androgen-independent Prostate Cancer 1 . Clin …

Muscle-invasive bladder cancers (MIBCs) are biologically heterogeneous and have widely
variable clinical outcomes and responses to conventional chemotherapy. We discovered …

Epidermal growth factor receptor (EGFR) regulates the growth and progression of human
transitional cell carcinoma (TCC) of the bladder. We have shown that therapy targeting EGFR …

The purpose of these studies was to determine whether systemic administration of IFN-α
can inhibit the expression of basic fibroblast growth factor (bFGF) in human transitional cell …

Interleukin 8 (IL-8) is mitogenic and chemotactic for endothelial cells. Within a neoplasm, IL-8
is secreted by inflammatory and neoplastic cells. The highly tumorigenic and highly …

Background BCG is the most effective therapy for high-risk non-muscle-invasive bladder
cancer. Nadofaragene firadenovec (also known as rAd-IFNa/Syn3) is a replication-deficient …

Purpose : We report stage specific followup guidelines based on our evaluation of the pattern
of recurrence in 286 patients treated for local N0 or Nx renal cell carcinoma. Materials and …